262 papers found
Refreshing results…
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
Isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
The Danish Melanoma Database
Cancer immunotherapy in patients with preexisting autoimmune disorders
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
Randomized phase III study comparing non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor-infiltrating lymphocytes and interleukin-2 to standard ipilimumab treatment in metastatic melanoma.
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Predictors of chemotherapy induced toxicity and treatment outcomes in elderly versus younger patients with metastatic castration-resistant prostate cancer
Immune Monitoring Using mRNA-Transfected Dendritic Cells
Large-Scale mRNA Transfection of Dendritic Cells by Electroporation in Continuous Flow Systems
Partially differentiated polyfunctional T cells dominate the periphery after tumor-infiltrating lymphocytes therapy for cancer
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes
Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2
Interferon- α induces marked alterations in circulating regulatory T cells, NK cell subsets and dendritic cells in patients with JAK2 V617F -positive essential thrombocythemia and polycythemia vera
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
Missing publications? Read more about our data sources.